Skip to main content
. 2020 Aug 28;11(10):2329–2339. doi: 10.1007/s13300-020-00910-1

Fig. 1.

Fig. 1

Efficacy outcomes of dulaglutide in patients aged ≥ 60 and < 60 years. a Change in HbA1c from baseline to week 26; b percentage of patients achieving HbA1c target (< 7.0%) at week 26; c change in FBG from baseline to week 26; d change in weight from baseline to week 26